• Associated Cardiomyopathy • Patients with End Stage Kidney Disease requiring Renal
Replacement Therapy. • Patients with extremely severe concomitant disease (severe dementia, advanced malignancy).
Acute NSTEMI was diagnosed according to the criteria of the ACCF/AHA. 5 Chronic kidney disease is defined through a range of estimated glomerular filtration rate (eGFR) values by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI). 6 Informed written consent was taken from each patient before enrollment. Meticulous history was taken regarding symptoms (chest pain or dyspnoea) and detailed clinical examination was performed. Demographic data and risk factors were recorded for all patients. Patient's baseline 12 lead ECG and Echocardiography were performed. Blood sample was taken for biochemical investigations including Troponin I, CK-MB, Random blood glucose, Hb%, Blood urea, Serum creatinine and Serum fasting lipid profile. Serum creatinine, lean body weight, gender and age were used to determine estimated GFR by Cockcroft and Gault formula. 7 Patients were stratified into 2 groups according to estimated GFR.
Prior to CAG, patients with CKD were treated with tab Nacetylcystine at a dose of 600-1200 mg orally twice daily, the day before and on the day of procedure and/ inj. NaHCO3 + 0.9% saline infusion at a rate of 1.0 ml/kg/hour for 1 h before the procedure and continued for 6 h after the procedure as premedication when LVEFe"40% to avoid contrast induced nephropathy. However, only Tab Nacetylcystine was used as premedication when LVEF<40% to avoid volume overload in CKD patients.
Coronary angiogram was performed in all patients and non-ionic iso-osmolar contrast agents (Iodixanol) were used in appropriate cases. Angiographic severity of CAD was assessed by evaluation of number of involved vessel, site of lesion, % of stenosis, ACC/AHA lesion classification (Type A, B, C) and TIMI flow grade between the groups. This percentage was calculated in the projection where the greatest narrowing would be observed. Significant coronary artery disease was defined as 70% or more luminal stenosis of major epicardial coronary arteries i.e. LAD, LCX or RCA and their branches or e"50% luminal narrowing of the left main coronary artery. Patients were classified as having SVD, DVD, TVD or LMD accordingly. 8 All necessary approval to perform the study was obtained from the Academic Council of National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
All the data were prospectively collected in a pre-designed data collection form. Group I = NSTEMI with CKD, Group II = NSTEMI without CKD,NS = Not Significant S = Significant, *Chi-square test was done to measure the level of significance Group I = NSTEMI with CKD, Group II = NSTEMI without CKD, S = Significant *t -test was done to measure the level of significance Group I = NSTEMI with CKD,Group II = NSTEMI without CKD,S = Significant,NS = Not Significant *Chi-square test was done to measure the level of significance. Group I = NSTEMI with CKD, Group II = NSTEMI without CKD, NS = Not Significant *Chi-square test was done to measure the level of significance.
Coronary 4 Kang, Jeong and Kim found that patients with NSTEMI with renal dysfunction had a significantly lower LVEF% (51±13% vs. 58±10%). 10 So, their findings were consistent with the findings of this study in that patients with CKD have reduced LVEF% than those with normal renal function.
The mean value of serum creatinine and estimated glomerular filtration rate were 1.7±0.2 mg/dL and 40.4±8.8 mL/min/1.73m² respectively in group I and 1±0.1 mg/dL and 76.3±1.4 mL/min/1.73m² respectively in group II. These differences were statistically significant (p<0.001). Hossain found identical mean serum creatinine and creatinine clearance rate (1.73 mg/dL ranged from 1.5-2.5 mg/dL and 39.9 mL/min ranged from 21-54 mL/min respectively in 80 CKD patients) with the current study. 15 Nearly similar pattern of mean serum creatinine and estimated glomerular filtration rate distribution were reported in different studies like Kang, Jeong and Kim, Wong, et al. and El-Menyar et al. 10, 11, 12 Anaemia is common in CKD patients; it usually correlates with the severity of renal failure and contributes to many of the non-specific symptoms of CKD. In this study, mean Hb% was 11.1±1.2 and 12.1±1.1 gm/dL in group I and group II respectively which was statistically significant (p<0.05). Hossain found mean Hb% was 11.6 gm/dL in 80 CKD patients. 15 Coronary angiography is a frequent component of the care of ACS patients. 5 After considering exclusion criteria total 152 patients were studied during hospital stay. But 128 of them underwent coronary angiography, among them 64 patients from group I and 64 patients from group II. Angiographic severity was assessed by evaluation of site of lesion, % of stenosis, lesion morphology, TIMI flow grading and number of coronary artery involvement between the groups.
Majority of the lesions were distributed in the proximal segment of all major coronary arteries among the study group.
Regarding the type of lesions, type A lesion was found 18.8%, 20.3% and 10.9% in group I while 15.6%, 14.1% and 12.5% in group II of LAD, LCX and RCA respectively. 16, 10 In group I, highest percentage had triple vessel disease 29 (45.3%) followed by double vessel disease 18(28.1%) and single vessel disease 10(15.6%). By contrast, highest percentage had single vessel disease 24(37.5%) followed by double vessel disease 17(26.6%) and triple vessel disease 16(25%) in group II. 7(10.9%) and 3(4.7%) had left main disease in group I and group II respectively. Noncritical coronary artery disease was found 5(7.8%) in group II but none in group I. 1(1.6%) had normal coronaries in group II but none in group I. Younger age was the strongest predictor of insignificant CAD in NSTEMI patients. 17 Kang, Jeong and Kim studied 181 NSTEMI patients with CKD and normal renal function by coronary angiography and observed that the number of involved vessel was higher in patients with more severe renal dysfunction in contrast to the prevalence of 1 vessel disease was increased according to increased GFR. TVD was present significantly in higher proportion of patients with CKD than patients with normal renal function (29.5% vs. 16.2%, p < 0.006). The reverse was noted with respect to SVD, which were 54.4% in patients with normal renal function and 34.6% in patients with CKD (p < 0.001). 10 Na, et al. demonstrated three-vessel disease (40.6% vs. 16.6%) and left main disease (13.7% vs. 8.7%) seemed to be more frequent in patients with CKD than those without CKD undergoing coronary angiography. 8 The CAG findings of this study parallels the above two studies.
In patients with NSTEMI with normal renal function, cardiac catheterization reveals angiographically normal coronary arteries or mild disease (all lesions <50%) in 10% to 20% of patients, single vessel disease in 30% to 35%, two vessel disease in 25% to 30%, three vessel disease in 20% to 25%, and left main artery disease in 5% to 10%. 18 In the study of Ali et al., CAG study of NSTEMI patients with normal renal function revealed that single vessel disease were 30%, double vessel disease 36.67%, triple vessel disease 20% and normal coronary artery 13.33%. 19 The higher incidence of multivessel coronary disease observed in the present study among patients with CKD may reflect a greater atherosclerotic burden than in patients with normal renal function.
Conclusions:
CKD strongly predicts severe coronary artery disease profile among NSTEMI patients. Compared to patients with normal renal function, CKD patients were significantly older, with a greater prevalence of hypertension, lower left ventricular ejection fraction and lower haemoglobin level. CKD was associated with an increased risk of triple vessel and left main disease. In contrast, the prevalence of single vessel disease was higher in patients with normal renal function. Other angiographic findings (TIMI flow, percent diameter stenosis, lesion classification) were not associated with GFR.
Study Limitations: Sample size was small. All the patients with NSTEMI with CKD were not included due to different contraindications and co-morbid conditions. All consecutive patients were not underwent coronary angiography.
